Showing results (101-110 of 275) with videos related to

Sort By:
Pageof 28
European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2018
Post-treatment positron emission tomography-computed tomography is highly predictive of outcome in Plasmablastic lymphomaYassine Al Tabaa, Emmanuelle Tchernonog, Pierre Faurie, et al.
Blood|October 13, 2018
BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatmentPatricia Gomez-Bougie, Sophie Maiga, Benoît Tessoulin, et al.
Journal of Cancer Research and Clinical Oncology|October 13, 2017
Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registriesAlix Augustin, Steven Le Gouill, Rémy Gressin, et al.
The Journal of Physical Chemistry Letters|January 28, 2021
Coulombic Force Gated Molecular Transport in Redox Flow BatteriesManu Gautam, Zahid M Bhat, Abdul Raafik, et al.
Future Oncology (London, England)|September 28, 2020
A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphomaMartin Dreyling, Constantine S Tam, Michael Wang, et al.
Leukemia|April 4, 2019
CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophagesAntonin Papin, Benoit Tessoulin, Céline Bellanger, et al.
Dalton Transactions (Cambridge, England : 2003)|October 30, 2014
Synthesis of tin nanocrystals in room temperature ionic liquidsSteven Le Vot, Damien Dambournet, Henri Groult, et al.
Bone Marrow Transplantation|December 20, 2017
Plerixafor in poor mobilizers with non-Hodgkin's lymphoma: a multi-center time-motion analysisMohamad Mohty, Nabih Azar, Christian Chabannon, et al.
Leukemia & Lymphoma|November 28, 2017
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendationsMartin Dreyling, Igor Aurer, Sergio Cortelazzo, et al.
Pageof 28